Hoekstra F, Knoop C, Aghai Z, Jutte N, Mochtar B, Bos E, Weimar W
Department of Internal Medicine I, University Hospital, Rotterdam, The Netherlands.
Ann Thorac Surg. 1995 Aug;60(2 Suppl):S131-3; discussion S133-4. doi: 10.1016/0003-4975(95)00273-n.
Both fresh and cryopreserved human cardiac valve allografts are transplanted without matching donor and recipient for blood group or human leukocyte antigens (HLA) and without the usual immunosuppressive therapy that follows organ transplantation. Calcification occurs in almost all transplanted valves, and in children acute valve failure is frequently seen. We hypothesized that failure of the human valve allografts could have an immunologic basis. This hypothesis was tested in a functional way by performing lymphocyte stimulation assays using fresh and cryopreserved valve pieces and endothelial cells derived from valve leaflets as stimulator. Human peripheral blood lymphocytes, both matched and mismatched for HLA antigens, were used as responder cells. The results were expressed as the stimulation index. Fresh valve pieces induced a significantly higher stimulation index (median, 9; range, 4 to 117) compared with the cryopreserved pieces (median, 2; range, 0 to 9; p = 0.002 by Wilcoxon test). The stimulation index was significantly reduced when lymphocytes matched for HLA-DR with the valve pieces were used (median, 1; range, 0 to 5) as compared with the HLA-DR-mismatched combination (median, 4; range, 2 to 117; p = 0.006, Wilcoxon test). Valve leaflet-derived endothelial cells were able to induce a median stimulation index of 8 (range, 3 to 15) when incubated with lymphocytes mismatched for HLA-A, -B, and -DR. In conclusion, stimulation of immune-competent cells in vitro is induced by both fresh and cryopreserved human valve pieces and by endothelial cells derived from fresh valve leaflets. The immune response can be reduced by using cryopreserved valves or by matching valve donor and responder lymphocytes for HLA-DR.(ABSTRACT TRUNCATED AT 250 WORDS)
新鲜和冷冻保存的人心脏瓣膜同种异体移植物在移植时,不进行供体与受体的血型或人类白细胞抗原(HLA)匹配,也不采用器官移植后常用的免疫抑制疗法。几乎所有移植的瓣膜都会发生钙化,并且在儿童中经常出现急性瓣膜功能衰竭。我们推测人瓣膜同种异体移植物的功能衰竭可能有免疫基础。通过使用新鲜和冷冻保存的瓣膜碎片以及来自瓣膜小叶的内皮细胞作为刺激物进行淋巴细胞刺激试验,以功能方式检验了这一假设。将HLA抗原匹配和不匹配的人外周血淋巴细胞用作反应细胞。结果以刺激指数表示。与冷冻保存的碎片(中位数为2;范围为0至9)相比,新鲜瓣膜碎片诱导的刺激指数显著更高(中位数为9;范围为4至117;Wilcoxon检验,p = 0.002)。与HLA-DR不匹配的组合(中位数为4;范围为2至117;Wilcoxon检验,p = 0.006)相比,当使用与瓣膜碎片HLA-DR匹配的淋巴细胞时,刺激指数显著降低(中位数为1;范围为0至5)。当与HLA-A、-B和-DR不匹配的淋巴细胞一起孵育时,瓣膜小叶来源的内皮细胞能够诱导中位数为8(范围为3至15)的刺激指数。总之,新鲜和冷冻保存的人瓣膜碎片以及新鲜瓣膜小叶来源的内皮细胞均可在体外诱导免疫活性细胞的刺激。通过使用冷冻保存的瓣膜或使瓣膜供体和反应淋巴细胞的HLA-DR相匹配,可以降低免疫反应。(摘要截取自250字)